DEF 14A: Definitive information statements
8-K: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
PRE 14A: Preliminary proxy statements relating to merger or acquisition
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 8-K: Current report
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | F-3: Registration statement for specified transactions by certain foreign private issuers
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEWAMSTERDAM PHARMA CO NV C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
No Data